TNC and myeloid sarcoma: The joint occurrence of CSPGs and tenascins in the ECM of MS patients as well as the reduced 473HD labeling in Tnc−/− and Tnr−/− brain sections might indicate that an interaction between the two ECM molecules could cooperate with regard to the inhibitory effect on remyelination (Ghorbani and Yong, 2021).